当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 现金流量表

科伦药业

(002422)

  

流通市值:451.45亿  总市值:552.45亿
流通股本:13.06亿   总股本:15.98亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,888,740,13421,640,073,66315,512,135,70410,336,605,807
  收到的税费返还29,260,900229,778,400205,102,054188,459,681
  收到其他与经营活动有关的现金92,026,541510,339,607328,836,758203,590,294
  经营活动现金流入小计5,010,027,57522,380,191,67016,046,074,51610,728,655,782
  购买商品、接受劳务支付的现金2,434,260,99911,438,946,6618,281,083,5655,301,731,454
  支付给职工以及为职工支付的现金1,212,096,1153,588,802,3942,805,721,9762,013,620,114
  支付的各项税费486,913,0802,365,767,1001,638,688,8411,136,899,242
  支付其他与经营活动有关的现金627,146,0642,344,607,2301,636,137,8021,086,870,095
  经营活动现金流出小计4,760,416,25819,738,123,38514,361,632,1849,539,120,905
  经营活动产生的现金流量净额249,611,3172,642,068,2851,684,442,3321,189,534,877
二、投资活动产生的现金流量:
  收回投资收到的现金7,730,308,00024,252,576,16420,206,939,31212,641,939,312
  取得投资收益收到的现金23,123,290170,522,117152,925,359110,526,769
  处置固定资产、无形资产和其他长期资产收回的现金净额1,447,69210,803,35411,340,69910,558,887
  处置子公司及其他营业单位收到的现金净额-11,898,47811,898,47811,357,500
  收到的其他与投资活动有关的现金---28,783,040
  投资活动现金流入小计7,754,878,98224,445,800,11320,383,103,84812,803,165,508
  购建固定资产、无形资产和其他长期资产支付的现金412,297,3611,622,489,7291,160,484,894766,900,166
  投资支付的现金8,136,936,72024,109,216,40020,595,031,61612,554,019,461
  取得子公司及其他营业单位支付的现金-2,354,95610,750,00010,750,000
  投资活动现金流出小计8,549,234,08125,734,061,08521,766,266,51013,331,669,627
  投资活动产生的现金流量净额-794,355,099-1,288,260,972-1,383,162,662-528,504,119
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,797,570,0521,797,570,0511,790,370,051
  其中:子公司吸收少数股东投资收到的现金-1,797,570,0521,797,570,0511,790,370,051
  取得借款收到的现金2,121,267,8244,656,527,8444,333,248,0911,997,040,000
  收到其他与筹资活动有关的现金483,704,507348,446,57350,938,71732,542,490
  筹资活动现金流入小计2,604,972,3316,802,544,4696,181,756,8593,819,952,541
  偿还债务支付的现金1,506,370,5544,671,387,9762,906,363,7321,496,363,732
  分配股利、利润或偿付利息支付的现金14,344,2641,331,140,7521,110,787,7971,088,476,768
  其中:子公司支付给少数股东的股利、利润-240,433,226240,433,306240,433,306
  支付其他与筹资活动有关的现金37,948,075115,986,46087,652,02367,127,929
  筹资活动现金流出小计1,558,662,8936,118,515,1884,104,803,5522,651,968,429
  筹资活动产生的现金流量净额1,046,309,438684,029,2812,076,953,3071,167,984,112
四、汇率变动对现金及现金等价物的影响-806,895-45,926,939-8,625,875-2,186,965
五、现金及现金等价物净增加额500,758,7611,991,909,6552,369,607,1021,826,827,905
  加:期初现金及现金等价物余额5,936,671,7293,944,762,0743,944,762,0743,944,762,074
  期末现金及现金等价物余额6,437,430,4905,936,671,7296,314,369,1765,771,589,979
补充资料:
  净利润-1,877,211,208-1,113,856,403
  资产减值准备-139,725,774-95,193,323
  固定资产和投资性房地产折旧-1,196,978,097-595,283,247
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,196,978,097-595,283,247
  无形资产摊销-126,597,495-61,700,262
  长期待摊费用摊销-20,468,303-10,871,020
  处置固定资产、无形资产和其他长期资产的损失--5,320,176--3,303,447
  固定资产报废损失-11,010,245--
  公允价值变动损失--27,611,838--15,139,177
  财务费用-148,403,066-53,096,611
  投资损失--210,412,627--139,968,737
  递延所得税--13,121,354-22,685,040
  其中:递延所得税资产减少--32,226,652-8,134,110
    递延所得税负债增加-19,105,298-14,550,930
  存货的减少--158,490,254-168,158,307
  经营性应收项目的减少--37,968,987--358,151,820
  经营性应付项目的增加--676,416,316--532,595,551
  其他-174,673,294-80,163,630
  现金的期末余额-5,936,671,729-5,771,589,979
  减:现金的期初余额-3,944,762,074-3,944,762,074
  现金及现金等价物的净增加额-1,991,909,655-1,826,827,905
公告日期2026-04-292026-04-032025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑